Cargando…

Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community

PURPOSE: Radiation dermatitis (RD) represents one of the most frequent side effects in radiotherapy (RT). Despite technical progress, mild and moderate RD still affects major subsets of patients and identification and management of patients with a high risk of severe RD is essential. We sought to ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Layer, Katharina, Layer, Julian P., Glasmacher, Andrea R., Sarria, Gustavo R., Böhner, Alexander M. C., Layer, Yonah L., Dejonckheere, Cas S., Garbe, Stephan, Feyer, Petra, Baumert, Brigitta G., Schendera, Anke, Baumann, René, Krug, David, Köksal, Mümtaz A., Koch, David, Scafa, Davide, Leitzen, Christina, Hölzel, Michael, Giordano, Frank A., Schmeel, Leonard Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542714/
https://www.ncbi.nlm.nih.gov/pubmed/37099166
http://dx.doi.org/10.1007/s00066-023-02074-w
_version_ 1785114151498022912
author Layer, Katharina
Layer, Julian P.
Glasmacher, Andrea R.
Sarria, Gustavo R.
Böhner, Alexander M. C.
Layer, Yonah L.
Dejonckheere, Cas S.
Garbe, Stephan
Feyer, Petra
Baumert, Brigitta G.
Schendera, Anke
Baumann, René
Krug, David
Köksal, Mümtaz A.
Koch, David
Scafa, Davide
Leitzen, Christina
Hölzel, Michael
Giordano, Frank A.
Schmeel, Leonard Christopher
author_facet Layer, Katharina
Layer, Julian P.
Glasmacher, Andrea R.
Sarria, Gustavo R.
Böhner, Alexander M. C.
Layer, Yonah L.
Dejonckheere, Cas S.
Garbe, Stephan
Feyer, Petra
Baumert, Brigitta G.
Schendera, Anke
Baumann, René
Krug, David
Köksal, Mümtaz A.
Koch, David
Scafa, Davide
Leitzen, Christina
Hölzel, Michael
Giordano, Frank A.
Schmeel, Leonard Christopher
author_sort Layer, Katharina
collection PubMed
description PURPOSE: Radiation dermatitis (RD) represents one of the most frequent side effects in radiotherapy (RT). Despite technical progress, mild and moderate RD still affects major subsets of patients and identification and management of patients with a high risk of severe RD is essential. We sought to characterize surveillance and nonpharmaceutical preventive management of RD in German-speaking hospitals and private centers. METHODS: We conducted a survey on RD among German-speaking radiation oncologists inquiring for their evaluation of risk factors, assessment methods, and nonpharmaceutical preventive management of RD. RESULTS: A total of 244 health professionals from public and private institutions in Germany, Austria, and Switzerland participated in the survey. RT-dependent factors were deemed most relevant for RD onset followed by lifestyle factors, emphasizing the impact of treatment conceptualization and patient education. While a broad majority of 92.8% assess RD at least once during RT, 59.0% of participants report RD at least partially arbitrarily and 17.4% stated to classify RD severity solely arbitrarily. 83.7% of all participants were unaware of patient-reported outcomes (PROs). Consensus exists on some lifestyle recommendations like avoidance of sun exposure (98.7%), hot baths (95.1%), and mechanical irritation (91.8%) under RT, while deodorant use (63.4% not at all, 22.1% with restrictions) or application of skin lotion (15.1% disapproval) remain controversial and are not recommended by guidelines or evidence-based practices. CONCLUSION: Identification of patients at an increased risk of RD and subsequent implementation of adequate preventive measures remain relevant and challenging aspects of clinical routines. Consensus exists on several risk factors and nonpharmaceutical prevention recommendations, while RT-dependent risk factors, e.g., the fractionation scheme, or hygienic measures like deodorant use remain controversial. Surveillance is widely lacking methodology and objectivity. Intensifying outreach in the radiation oncology community is needed to improve practice patterns. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00066-023-02074-w) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-10542714
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105427142023-10-03 Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community Layer, Katharina Layer, Julian P. Glasmacher, Andrea R. Sarria, Gustavo R. Böhner, Alexander M. C. Layer, Yonah L. Dejonckheere, Cas S. Garbe, Stephan Feyer, Petra Baumert, Brigitta G. Schendera, Anke Baumann, René Krug, David Köksal, Mümtaz A. Koch, David Scafa, Davide Leitzen, Christina Hölzel, Michael Giordano, Frank A. Schmeel, Leonard Christopher Strahlenther Onkol Original Article PURPOSE: Radiation dermatitis (RD) represents one of the most frequent side effects in radiotherapy (RT). Despite technical progress, mild and moderate RD still affects major subsets of patients and identification and management of patients with a high risk of severe RD is essential. We sought to characterize surveillance and nonpharmaceutical preventive management of RD in German-speaking hospitals and private centers. METHODS: We conducted a survey on RD among German-speaking radiation oncologists inquiring for their evaluation of risk factors, assessment methods, and nonpharmaceutical preventive management of RD. RESULTS: A total of 244 health professionals from public and private institutions in Germany, Austria, and Switzerland participated in the survey. RT-dependent factors were deemed most relevant for RD onset followed by lifestyle factors, emphasizing the impact of treatment conceptualization and patient education. While a broad majority of 92.8% assess RD at least once during RT, 59.0% of participants report RD at least partially arbitrarily and 17.4% stated to classify RD severity solely arbitrarily. 83.7% of all participants were unaware of patient-reported outcomes (PROs). Consensus exists on some lifestyle recommendations like avoidance of sun exposure (98.7%), hot baths (95.1%), and mechanical irritation (91.8%) under RT, while deodorant use (63.4% not at all, 22.1% with restrictions) or application of skin lotion (15.1% disapproval) remain controversial and are not recommended by guidelines or evidence-based practices. CONCLUSION: Identification of patients at an increased risk of RD and subsequent implementation of adequate preventive measures remain relevant and challenging aspects of clinical routines. Consensus exists on several risk factors and nonpharmaceutical prevention recommendations, while RT-dependent risk factors, e.g., the fractionation scheme, or hygienic measures like deodorant use remain controversial. Surveillance is widely lacking methodology and objectivity. Intensifying outreach in the radiation oncology community is needed to improve practice patterns. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00066-023-02074-w) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2023-04-26 2023 /pmc/articles/PMC10542714/ /pubmed/37099166 http://dx.doi.org/10.1007/s00066-023-02074-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Layer, Katharina
Layer, Julian P.
Glasmacher, Andrea R.
Sarria, Gustavo R.
Böhner, Alexander M. C.
Layer, Yonah L.
Dejonckheere, Cas S.
Garbe, Stephan
Feyer, Petra
Baumert, Brigitta G.
Schendera, Anke
Baumann, René
Krug, David
Köksal, Mümtaz A.
Koch, David
Scafa, Davide
Leitzen, Christina
Hölzel, Michael
Giordano, Frank A.
Schmeel, Leonard Christopher
Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community
title Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community
title_full Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community
title_fullStr Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community
title_full_unstemmed Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community
title_short Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community
title_sort risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the german-speaking radiation oncology community
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542714/
https://www.ncbi.nlm.nih.gov/pubmed/37099166
http://dx.doi.org/10.1007/s00066-023-02074-w
work_keys_str_mv AT layerkatharina riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT layerjulianp riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT glasmacherandrear riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT sarriagustavor riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT bohneralexandermc riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT layeryonahl riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT dejonckheerecass riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT garbestephan riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT feyerpetra riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT baumertbrigittag riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT schenderaanke riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT baumannrene riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT krugdavid riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT koksalmumtaza riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT kochdavid riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT scafadavide riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT leitzenchristina riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT holzelmichael riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT giordanofranka riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT schmeelleonardchristopher riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity
AT riskassessmentsurveillanceandnonpharmaceuticalpreventionofacuteradiationdermatitisresultsofamulticentricsurveyamongthegermanspeakingradiationoncologycommunity